Personalizing Everything: Health Care is AI’s Hardest and Highest-Value Patient

October 8, 2026
You must provide your professional email address to view this content.
  • Personalization that AI promises depends on three variables: the cost of acquiring data, the cost of a wrong prediction and the speed of the feedback loop. Health care sits at the extreme on all three, so it has the strongest scientific case for personalization and the highest risk of overpromising.
  • Merck and Moderna reported the first positive Phase 3 result for an individualized neoantigen therapy in August, and Moderna’s shares nearly doubled, creating optimism that personalization can be applied to cancer treatments.
  • Favor the supply chain over the therapy owners: Biotech companies carry the regulatory, clinical and commercial risk, while suppliers of data generation, data-to-decision tools and manufacturing capacity carry less of it.

 

Artificial intelligence offers incredible potential to tailor medicine in a way that was previously prohibitively costly or technologically unfeasible. However, this high-impact sector also brings with it big risks for those intending to market treatments. A lower risk strategy is to own a basket of “picks and shovels” of the supply chain: data generation, data to decision and specialized manufacturers.

Disclaimer / Securities Disclosure

The author(s) of this research note do (does) not personally hold a any position in any of the above-mentioned securities.

DISCLAIMER
© Sustainable Market Strategies, a division of SMS Financial Technologies inc. Redistribution prohibited without prior consent. This report has been prepared by Sustainable Market Strategies mainly for distribution to market professionals and institutional investors. It should not be considered as investment advice or a recommendation to purchase any particular security, strategy, or investment product. References to specific securities and issuers are not intended to be, and should not be interpreted as, recommendations to purchase or sell such securities. Information contained herein has been obtained from sources believed to be reliable, but not guaranteed.